Karra, Nour <br/><br/>
Safety and proof-of-concept efficacy of inhaled drug loaded nano- and immunonanoparticles in a c-Raf transgenic lung cancer model.  [electronic resource] 

 -  Current cancer drug targets  Jan 2013 
 - 11-29 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-5576 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Animals<br/>Antibodies, Immobilized--administration & dosage<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Neoplasm--administration & dosage<br/>Antigens, Neoplasm--metabolism<br/>Antineoplastic Agents, Phytogenic--administration & dosage<br/>Cell Adhesion Molecules--antagonists & inhibitors<br/>Disease Models, Animal<br/>Drug Delivery Systems--adverse effects<br/>Epithelial Cell Adhesion Molecule<br/>Female<br/>Humans<br/>Lung--drug effects<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Mice<br/>Mice, Transgenic<br/>Nanoparticles--administration & dosage<br/>Paclitaxel--administration & dosage<br/>Palmitates--administration & dosage<br/>Proto-Oncogene Proteins c-raf--genetics<br/>Random Allocation<br/>Surface Properties<br/>Survival Analysis